Post a Free Blog

Submit A Press Release

Friday, March 29, 2024
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
Filter by Categories
Action
Animation
ATP Tour (ATP)
Auto Racing
Baseball
Basketball
Boxing
Breaking News
Business
Business
Business Newsletter
Call of Duty (CALLOFDUTY)
Canadian Football League (CFL)
Car
Celebrity
Champions Tour (CHAMP)
Comedy
CONCACAF
Counter Strike Global Offensive (CSGO)
Crime
Defense of the Ancients (DOTA)
Documentary and Foreign
Drama
eSports
European Tour (EPGA)
Fashion
FIFA
FIFA Women’s World Cup (WWC)
FIFA World Cup (FIFA)
Fighting
Football
Formula 1 (F1)
Fortnite
Golf
Health
Hockey
Horror
IndyCar Series (INDY)
International Friendly (FRIENDLY)
Kids & Family
League of Legends (LOL)
LPGA
Madden
Major League Baseball (MLB)
Mixed Martial Arts (MMA)
MLS
Movie and Music
Movie Trailers
Mystery
NASCAR Cup Series (NAS)
National Basketball Association (NBA)
National Football League (NFL)
National Hockey League (NHL)
National Women's Soccer (NWSL)
NBA Development League (NBAGL)
NBA2K
NCAA Baseball (NCAABBL)
NCAA Basketball (NCAAB)
NCAA Football (NCAAF)
NCAA Hockey (NCAAH)
Olympic Mens (OLYHKYM)
Other
Other Sports
Overwatch
PGA
Politics
Premier League (PREM)
Romance
Sci-Fi
Science
Soccer
Sports
Sports
Technology
Tennis
Truck Series (TRUCK)
Ultimate Fighting Championship (UFC)
Uncategorized
US
Valorant
Women’s National Basketball Association (WNBA)
Women’s NCAA Basketball (WNCAAB)
World
World Cup Qualifier (WORLDCUP)
WTA Tour (WTA)
Xfinity (XFT)
XFL
-- Advertisement --spot_img
HomeBusinessSputnik V rejected by Brazil’s health regulator: Russia says 61 countries have...

Sputnik V rejected by Brazil’s health regulator: Russia says 61 countries have approve its COVID-19 vaccine

 

On Monday, Anvisa, which is the health regulator in Brazil, rejected a request by state governments to import Sputnik V, the COVID-19 vaccine made in Russia. All five board members voted against its approval saying it has “inherent risks” and “serious defects.” The Russian Direct Investment Fund (RDIF) who markets the vaccine said that this may be a politically motivated decision as 61 countries have approved its use and it has a high efficacy rate.

 

The general manager for health monitoring, Ana Carolina Moreira Marino Araujo said that they had reviewed the documentation presented as well as checked in-person data and obtained information from other regulators. They concluded that the “inherent risks” in Sputnik V were too great to be used in Brazil.

 

 

Brazil’s vaccination program has been beset with delays. The country is a hotspot for COVID-19. The health system is unable to cope with the daily rising numbers. A judicial enquiry on the lapses to procure oxygen is also underway.

 

According to data from the health ministry about 13 percent of the population which amounts to 27.3 million people has received a first dose of a COVId-19 vaccine. The country registered 14.4 million confirmed COVID-19 infections. The total death toll has also been one of the highest in the world and is reported to be almost 400,000.

 

Sputnik V is an adenovirus vaccine similar to vaccines produced by AstraZeneca and Johnson and Johnson. Clinical trials put its efficacy at almost 92 percent. A statement released by Moscow’s Gamaleya Institute where the vaccine was developed and the Russian Direct Investment Fund said that the real-world assessment produced better results. Data procured from 3.8 million who have taken the vaccine showed that Sputnik V was 97.6 percent effective.

 

European Medicines Agency, which is the European Union’s regulator, is reviewing Sputnik V. It is expected to decide whether it will use this vaccine by May or June.

 

Subscribe to get Latest News Updates

Latest News Articles

You may like more
more

Semtech Shares Jump 3 percent Following Q4 Results

Semtech (NASDAQ:SMTC) experienced a more than 3% increase in...

Target Stock Added to Fresh Money List at Deutsche Bank

Deutsche Bank analysts placed Target (NYSE:TGT) on the Fresh...

AMC Shares Plunge 14 percent on a New Equity Distribution Deal

AMC Entertainment Holdings (NYSE:AMC) saw its shares drop over...

Palantir Technologies Stock Drops 6 percent on Monness, Crespi, Hardt Downgrade

Palantir Technologies (NYSE:PLTR) stock plunged more than 6% on...